Revisional Metabolic and Bariatric Surgery Versus Semaglutide: Which Strategy Has Greater Efficacy for Recurrent Weigh Gain After Primary Bariatric Surgery?
Semaglutide in the Spotlight: How Does It Stack Up Against Revisional Bariatric Surgery?
Obes Surg
by Rivero-Moreno Y, Estrada A, Zamata-Ovalle D et al.
“Revisional Metabolic and Bariatric Surgery Versus Semaglutide: Which Strategy Has Greater Efficacy for Recurrent Weigh Gain After Primary Bariatric Surgery? Rivero-Moreno Y(1), Estrada A(1), Zamata-Ovalle D(1), Hindosh N(1), Oviedo R(2)(3), Choi J(1), Moran-Atkin E(1), Camacho D(1). Author information: (1)Montefiore Medical Center, The Bronx, USA. (2)Department of surgery, Nacogdoches Medical Center, Nacogdoches, USA. roviedo3@central.uh.edu. (3)Sam Houston State University College of Osteopathic Medicine, Conroe, USA. roviedo3@central.uh.edu. Conflict of interest statement: Declarations. Ethics Approval and Consent to Participate: Ethics approval was provided by an institutional Human Research Ethics Committee. Consent for Publication: Informed consent was not required for this study as it utilizes de-identified data. Competing Interests: The authors declare no competing interests. Data Sharing Statement: The de-identified data we analyzed are not publicly available, but requests to the corresponding author for the data will be considered case-by-case.”
Semaglutide is getting real attention from researchers looking for solutions to weight regain after bariatric surgery. A new study out of Montefiore Medical Center compared semaglutide to revisional metabolic and bariatric surgery for people who had put weight back on after their first procedure. This is a big question in the obesity research world: do you go back under the knife, or try a research peptide like semaglutide?
The team analyzed outcomes in patients who experienced weight recurrence post-bariatric surgery. They looked at two groups: those who underwent a second (revisional) surgery, and those who were given semaglutide as a non-surgical alternative. The goal was simple—find out which strategy helps people lose more weight and keep it off.
Key findings:
Semaglutide led to significant weight loss for many participants, even after previous surgery.
Revisional surgery also produced weight loss, but came with the usual surgical risks and a longer recovery.
The non-invasive nature of semaglutide made it an attractive option, especially for those hesitant about another operation.
Researchers pointed out that managing weight regain is a complex challenge, and both approaches have their place in the research pipeline. The flexibility of semaglutide—administered as a research peptide rather than a surgical intervention—means more options for future studies and for the broader research community.
Semaglutide continues to prove itself as a heavyweight in metabolic research. With surgical and non-surgical options on the table, researchers now have more tools than ever to tackle weight recurrence after bariatric surgery. This study just adds more momentum to ongoing peptide research.
Related Reading
Reply: Semaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment.
News · JACC Heart FailSemaglutide in Frail HFpEF: Need for Objective Functional Measures and Body Composition Assessment.
News · NeuropsychopharmacologyIdentification of an intrusive-hypervigilant phenotype of posttraumatic stress symptoms with unique stress peptide and amygdala functional connectivity profiles.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.